Pre-pulse inhibition and striatal dopamine in subjects at an ultra-high risk for psychosis
De Koning, M.B., Bloemen, O.J.N., van Duin, E.D.A., Booij, J., Abel, K.M.,
De Haan, L., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Journal of Psychopharmacology, 28 (6), 553-560 (2014)
Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis
Bloemen, O.J.N.,
De Koning, M.B., Gleich, T., Meijer, J.,
De Haan, L., Linszen, D.H., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in European Neuropsychopharmacology, 23 (2), 126-132 (2013)
Startle reactivity and prepulse inhibition of the acoustic startle response are modulated by catechol-O-methyl-transferase Val158Met polymorphism in adults with 22q11 deletion syndrome
De Koning, M.B., Boot, E., Bloemen, O.J.N., van Duin, E.D.A., Abel, K.M.,
De Haan, L., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Journal of Psychopharmacology, 26 (12), 1548-1560 (2012)
Hippocampal Glutamate Levels and Striatal Dopamine D2/3 Receptor Occupancy in Subjects at Ultra High Risk of Psychosis
Bloemen, O.J.N., Gleich, T.,
De Koning, M.B., da Silva Alvis, F.,
De Haan, L., Linszen, D.H., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Biological Psychiatry, 70 (1), e1-e2 (2011)
White-matter markers for psychosis in a prospective ultra-high-risk cohort
Bloemen, O.J.N.,
De Koning, M.B., Schmitz, N., Nieman, D.H., Becker, H.E.,
De Haan, L., Dingemans, P., Linszen, D.H. & van Amelsvoort, T.A.M.J.
Verschenen in Psychological Medicine, 40 (8), 1297-1304 (2010)
Early intervention in patients at ultra high risk of psychosis: benefits and risks.
De Koning, M.B., Bloemen, O.J.N., van Amelsvoort, T.A.M.J., Becker, H.E., Nieman, D.H., van der Gaag, M. & Linszen, D.H.
Verschenen in Acta Psychiatrica Scandinavia, 119 (6), 426-442 (2009)
Challenge and therapeutic studies using alpha-methyl-para-tyrosine (AMPT) in neuropsychiatric disorders: a review
Bloemen, O.J.N.,
De Koning, M.B., Boot, E., Booij, J. & van Amelsvoort, T.A.M.J.
Verschenen in Central Nervous System Agents in Medicinal Chemistry, 8 (4), 249-256 (2008)
